Lattice Biologics Ltd. announced earnings results for the full year ended September 30, 2018. For the full year, the company announced sales was USD 1.155 million compared to USD 2.739 million a year ago. Operating loss was USD 1.329 million compared to USD 2.589 million a year ago. Net loss was USD 1.231 million compared to USD 1.524 million a year ago. Basic loss per share was USD 0.01 compared to USD 0.02 a year ago.